Sensei Biotherapeutics, Inc.

ROCKVILLE, MD · CIK 0001829802 · Biotech · Public

Small molecule inhibitors targeting the PI3K/AKT/mTOR signaling pathway

faeththerapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$349M
1 Form D · Mar 2026
7 months since last filing
Contracts
—
No federal contracts on record
Patents
17
1 granted · 16 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$348,906,500
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2780Tentarix——
2781Instil Bio, Inc.—$371M
2782Legend Biotech Corp—$350M
2783Sensei Biotherapeutics, Inc.—$349M
2784X4 Pharmaceuticals—$313M
2785Nuvation Bio—$275M
2786CELL REPROGRAMMING & THERAPEUTICS LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • Josiah CraverExecutive Officer
  • Phillip DonenbergDirector
  • Christopher GerryDirector · Executive Officer
  • Bob HolmenDirector
  • Kristian HumerDirector
  • Anand ParikhDirector · Executive Officer
  • Tom RicksDirector

Patents

USPTO · 1 granted of 17
  • Modified Antibodies And Related Compounds, Compositions And Methods Of Usegranted
  • Anti-vista Antibodies And Uses Thereofapplication
  • Combination Therapies For Cancerapplication
  • Compositions And Methods For Manufacturing Bacteriophage Cancer Vaccines And Uses Thereofapplication
  • Aspartate Beta-hydroxylase Chimeric Antigen Receptors And Uses Thereofapplication
  • Compositions And Methods For Manufacturing Bacteriophage Cancer Vaccines And Uses Thereofapplication
  • Aspartate Beta-hydroxylase Chimeric Antigen Receptors And Uses Thereofapplication
  • Combination Therapies For Cancerapplication
  • Compositions And Methods For Manufacturing Bacteriophage Cancer Vaccinesapplication
  • Aspartate Beta-hydroxylase Chimeric Antigen Receptors And Uses Thereofapplication
  • Compositions And Methods For Manufacturing Bacteriophage Cancer Vaccinesapplication
  • Bispecific Anti-vista And ANTI-CD28 Binding Proteins And Uses Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.